CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
5.84
+0.09 (1.57%)
At close: Sep 11, 2026, 4:00 PM EDT
5.78
-0.06 (-1.03%)
After-hours: Sep 11, 2026, 7:30 PM EDT
CNS Pharmaceuticals Employees
CNS Pharmaceuticals had 8 employees as of December 31, 2025. The number of employees increased by 3 or 60.00% compared to the previous year.
Employees
8
Change (1Y)
3
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$2,087,446
Market Cap
8.53M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 8 | 3 | 60.00% | 8 | 0 |
| Dec 31, 2024 | 5 | 0 | - | 4 | 1 |
| Dec 31, 2023 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2022 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2021 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Senti Biosciences Holdings | 39 |
| Evogene | 38 |
| Bolt Biotherapeutics | 23 |
| Imunon | 20 |
| Soligenix | 14 |
| Traws Pharma | 7 |
| Alzamend Neuro | 6 |
| XTL Biopharmaceuticals | 5 |
CNSP News
- 12 days ago - CNS Pharmaceuticals details business development strategy - TheFly
- 12 days ago - CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth - Accesswire
- 17 days ago - CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference - Accesswire
- 19 days ago - CNS Pharmaceuticals Proxy statement: Proxy filing - Filings
- 23 days ago - CNS Pharmaceuticals Proxy statement: Proxy filing - Filings
- 27 days ago - CNS Pharmaceuticals Slides: Investor presentation - Filings
- 27 days ago - CNS Pharmaceuticals reports Q2 EPS (37c) vs. ($6.42) last year - TheFly
- 27 days ago - CNS Pharmaceuticals ‘actively evaluating’ business devlopment opportunities - TheFly